Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation (original) (raw)

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18:1221–1231. doi:10.1056/NEJMra011775.
  Article Google Scholar
• Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003;18:124–138. doi:10.1046/j.1440-1746.2003.02989.x.
  Article PubMed Google Scholar
• Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1998;95:1056–1062.
  Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438.
  CAS PubMed Google Scholar
• Yoneda M, Mawatari H, Fujita K, et al. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007;42:375–381. doi:10.1007/s00535-007-2014-3.
  Article CAS PubMed Google Scholar
• Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42:573–582. doi:10.1007/s00535-007-2060-x.
  Article CAS PubMed Google Scholar
• Yoneda M, Uchiyama T, Kato S, et al. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol. 2008;8:53. doi:10.1186/1471-230X-8-53.
  Article PubMed Google Scholar
• Yoneda M, Yoneda M, Fujita K, et al. Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330–1331. doi:10.1136/gut.2007.126417.
  Article PubMed Google Scholar
• Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008;40:371–378. doi:10.1016/j.dld.2007.10.019.
  Article CAS PubMed Google Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750. doi:10.1053/gast.2002.35354.
  Article PubMed Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hit”? Gastroenterology. 1998;114:842–845. doi:10.1016/S0016-5085(98)70599-2.
  Article CAS PubMed Google Scholar
• George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311–318. doi:10.1016/S0016-5085(98)70482-2.
  Article CAS PubMed Google Scholar
• James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998;29:495–501. doi:10.1016/S0168-8278(98)80073-1.
  Article CAS PubMed Google Scholar
• Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol. 1999;31:421–429. doi:10.1016/S0168-8278(99)80032-4.
  Article CAS PubMed Google Scholar
• Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999;117:1155–1163. doi:10.1016/S0016-5085(99)70401-4.
  Article CAS PubMed Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi:10.1007/BF00280883.
  Article CAS PubMed Google Scholar
• Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–286.
  CAS PubMed Google Scholar
• Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;21:27–41.
  Google Scholar
• Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3–16. doi:10.1055/s-2001-12925.
  Article CAS PubMed Google Scholar
• Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. doi:10.1038/ng0896-399.
  Article CAS PubMed Google Scholar
• Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology. 1999;116:127–134. doi:10.1016/S0016-5085(99)70236-2.
  Article CAS PubMed Google Scholar
• Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology. 1998;114:319–323. doi:10.1016/S0016-5085(98)70483-4.
  Article CAS PubMed Google Scholar
• Hayashi H, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994;89:986–988.
  CAS PubMed Google Scholar
• Sumida Y, Kanemasa K, Fukumoto K, et al. Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: a pilot study. Hepatol Res. 2006;36:315–321. doi:10.1016/j.hepres.2006.08.003.
  Article CAS PubMed Google Scholar
• Videla LA, Fernández V, Tapia G, et al. Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals. 2003;16:103–111. doi:10.1023/A:1020707811707.
  Article CAS PubMed Google Scholar
• Houglum K, Filip M, Witztum JL, et al. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest. 1990;86:1991–1998. doi:10.1172/JCI114934.
  Article CAS PubMed Google Scholar
• Kadiiska MB, Burkitt MJ, Xiang QH, et al. Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation. J Clin Invest. 1995;96:1653–1657.
  Article CAS PubMed Google Scholar
• Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol. 1998;28(suppl 1):8–13. doi:10.1016/S0168-8278(98)80368-1.
  Article CAS PubMed Google Scholar
• Lustbader ED, Hann HW, Blumberg BS. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science. 1983;220:423–425. doi:10.1126/science.6301008.
  Article CAS PubMed Google Scholar
• Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet. 1996;14:249–251. doi:10.1038/ng1196-249.
  Article CAS PubMed Google Scholar
• Douabin V, Deugnier Y, Jouanolle AM, et al. Polymorphisms in the haemochromatosis gene. International Symposium on iron in biology and medicine. Saint-Malo, France, 1997, p 267.
• Chitturi S, Weltman M, Farrell GC, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 2002;36:142–149. doi:10.1053/jhep.2002.33892.
  Article CAS PubMed Google Scholar
• Deguti MM, Sipahi AM, Gayotto LC, et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res. 2003;36:739–745. doi:10.1590/S0100-879X2003000600009.
  Article CAS PubMed Google Scholar
• Duseja A, Das R, Nanda M, et al. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol. 2005;11:393–395.
  PubMed Google Scholar
• Yamauchi N, Itoh Y, Tanaka Y, et al. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis. J Gastroenterol. 2004;39:654–660. doi:10.1007/s00535-003-1361-y.
  Article CAS PubMed Google Scholar
• Sohda T, Yanai J, Soejima H, et al. Frequencies in the Japanese population of HFE gene mutations. Biochem Genet. 1999;37:63–68. doi:10.1023/A:1018718101579.
  Article CAS PubMed Google Scholar
• Dobbins RL, Szczepaniak LS, Myhill J, et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes. 2002;51:1825–1833. doi:10.2337/diabetes.51.6.1825.
  Article CAS PubMed Google Scholar
• Dongiovanni P, Valenti L, Ludovica Fracanzani A, et al. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol. 2008;172:738–747. doi:10.2353/ajpath.2008.070097.
  Article CAS PubMed Google Scholar
• Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102:1251–1258. doi:10.1111/j.1572-0241.2007.01192.x.
  Article CAS PubMed Google Scholar
• Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373–379. doi:10.1053/jhep.2002.30692.
  Article CAS PubMed Google Scholar